Eric Topol/X;
Leslie Skeith/ucalgary.ca; Shannon M. Bates/fwgbd.org
Apr 17, 2026, 14:34
Eric Topol: The Role of Sex Hormones in Venous Thromboembolism and Cardiovascular Disease Risk
Eric Topol, Founder and Director of Scripps Research Translational Institute, shared a post on X about a recent article by Leslie Skeith, published in NEJM:
“Sex hormones, clotting disorders, and cardiovascular risk – An important new NEJM review for MHT and testosterone latest data.”
Title: Sex Hormone Influences on Venous Thrombotic and Cardiovascular Risk
Authors: Leslie Skeith, Shannon M. Bates
Other posts featuring Eric Topol on Hemostasis Today.
-
Sep 4, 2026, 05:38Faizan Khan: Why Common Exposures Matter in VTE Risk
-
Sep 4, 2026, 04:56Marwa Mostafa: Microcytosis Is Not Always Iron Deficiency
-
Sep 4, 2026, 03:18Mukesh Kumar Maurya: Beyond ‘aPL Thrombosis’ – A Modern Approach to APS
-
Sep 4, 2026, 02:44Ahmed Kotb: Emergency Management of Critical Bleeding in ITP
-
Sep 4, 2026, 02:30Mario Jimenez: KDIGO 2026 – A More Proactive Approach to IV Iron in Hemodialysis
-
Sep 4, 2026, 02:18Edgardo Alania: Edoxaban in Intracranial Haemorrhage Survivors with AF
-
Sep 3, 2026, 20:33Jennifer Weinstein: Happy to Share Our New Work on the Patient Experience in VWD at the NBDF Conference
-
Sep 3, 2026, 20:31Guillaume Courbon: New Publication on Erythroid-Produced FGF23 and Its Role in Anemia
-
Sep 3, 2026, 20:30Phuong Khanh Morrow: FDA Approval Marks an Important Step Forward for the PV Community